高免疫グロブリンの世界市場レポート 2025年

高免疫グロブリン市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.6％で27億6,000万米ドルに成長します。予測期間の成長は、感染症の流行増加、高免疫グロブリン注射の利点に関する意識の高まり、免疫グロブリンの需要増加、α-1抗トリプシン欠乏症の有病率上昇、免疫不全の発生率上昇に起因すると考えられます。予測期間における主な動向としては、技術の進歩と革新、研究開発への投資、受動免疫治療への需要、血漿由来治療の進歩、製造技術の進歩などが挙げられます。

高免疫グロブリン市場は、感染症の蔓延の増加により成長するとみられます。ウイルス、細菌、真菌、寄生虫などの病原体によって引き起こされるこれらの疾患は、抗菌薬耐性、気候変動、人口増加などの要因により増加傾向にあります。高免疫グロブリンは、特定の病原体を標的とする濃縮抗体を介して即時受動免疫を提供することにより、感染症との闘いに重要な役割を果たしています。これは、2021年から2022年にかけて米国での患者数が17％増加したB型慢性肝炎などの例に見られるように、疾患の予防や治療に役立ちます。したがって、感染症の増加は高免疫グロブリン市場に直接的な影響を与えています。

ヘルスケアの研究開発を推進する政府の取り組みは、今後数年間で高免疫グロブリン市場を押し上げる構えです。こうした取り組みは、革新的な医療ソリューションに対する需要の高まりや、新たな健康問題に立ち向かう必要性から活発化しています。高免疫グロブリンの開発とアクセシビリティを促進し、特に特定の感染症に効果的に対処する上で重要な役割を果たしています。例えば、英国政府は2022年、ビジネス・エネルギー・産業戦略（BEIS）および保健社会ケア省（DHSC）を通じて、2億6,000万ポンド（2億7,065万米国ドル）を医療研究と製造の強化に割り当てた。この資金は、NHS主導の健康研究、診断と治療のためのプライバシーを保護する新しいプラットフォーム、臨床研究サービスを支援するもので、英国内のライフサイエンス製造業を強化するための6,000万ポンド（6,360万米国ドル）も含まれています。したがって、ヘルスケア研究開発に対する政府の注目の高まりが、高免疫グロブリン市場の主要促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界高免疫グロブリンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の高免疫グロブリン市場：成長率分析
• 世界の高免疫グロブリン市場の実績：規模と成長, 2019-2024
• 世界の高免疫グロブリン市場の予測：規模と成長, 2024-2029, 2034F
• 世界高免疫グロブリン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の高免疫グロブリン市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• B型肝炎高免疫グロブリン
• 狂犬病高免疫グロブリン
• 破傷風高免疫グロブリン
• サイトメガロウイルス（CMV）高免疫グロブリン
• 水痘帯状疱疹ウイルス（VZV）高免疫グロブリン
• RSウイルス（RSV）高免疫グロブリン
• その他のタイプ
• 世界の高免疫グロブリン市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 筋肉内
• 静脈内
• 世界の高免疫グロブリン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 政府機関
• 民間部門
• その他の用途
• 世界の高免疫グロブリン市場B型肝炎高免疫グロブリンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 筋肉内B型肝炎高免疫グロブリン
• 静脈内B型肝炎高免疫グロブリン
• 世界の高免疫グロブリン市場狂犬病高免疫グロブリンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 狂犬病免疫グロブリン（ヒト）
• 狂犬病免疫グロブリン（馬）
• 世界の高免疫グロブリン市場破傷風高免疫グロブリンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 破傷風免疫グロブリン（ヒト）
• 破傷風免疫グロブリン（馬）
• 世界の高免疫グロブリン市場サイトメガロウイルス（CMV）高免疫グロブリンのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臓器移植のためのCMV免疫グロブリン
• 新生児感染症に対するCMV免疫グロブリン
• 世界の高免疫グロブリン市場水痘帯状疱疹ウイルス（VZV）高免疫グロブリンのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 曝露後予防のためのVZV免疫グロブリン
• 免疫不全患者のためのVZV免疫グロブリン
• 世界の高免疫グロブリン市場RSウイルス（RSV）高免疫グロブリンのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 乳幼児用RSウイルス免疫グロブリン
• 呼吸器疾患の成人に対するRSV免疫グロブリン
• 世界の高免疫グロブリン市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ジフテリア高免疫グロブリン
• ボツリヌス菌高免疫グロブリン
• その他の専門高免疫グロブリン

第7章 地域別・国別分析

• 世界の高免疫グロブリン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の高免疫グロブリン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 高免疫グロブリン市場：競合情勢
• 高免疫グロブリン市場：企業プロファイル
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • CSL Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Fresenius Kabi AG
• Grifols SA
• Octapharma AG
• Shanghai RAAS Blood Products Co. Ltd.
• Emergent BioSolutions Inc.
• Kedrion Biopharma Inc.
• LFB SA
• Hualan Biological Engineering Inc.
• FFF Enterprises Inc.
• Taibang Biologic Group
• Bio Products Laboratory（BPL）Ltd.
• ADMA Biologics
• Cangene Corporation
• Kamada Ltd.
• Saol Therapeutics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 高免疫グロブリン市場2029：新たな機会を提供する国
• 高免疫グロブリン市場2029：新たな機会を提供するセグメント
• 高免疫グロブリン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Hyperimmune globulins are specialized preparations of antibodies enriched with specific antibodies against a particular pathogen or antigen. These preparations are obtained from the plasma of individuals who have high levels of antibodies against a specific infectious agent or toxin. They are utilized for passive immunization to confer immediate immunity against certain diseases, particularly in situations requiring prompt protection.

The primary types of hyperimmune globulins include hepatitis B hyperimmune globulin, rabies hyperimmune globulin, tetanus hyperimmune globulin, cytomegalovirus (CMV) hyperimmune globulin, varicella-zoster virus (VZV) hyperimmune globulin, respiratory syncytial virus (RSV) hyperimmune globulin, among others. Hepatitis B hyperimmune globulin, for example, is derived from the plasma of donors with high antibody titers against the hepatitis B virus. These preparations are administered via various routes such as intramuscular or intravenous, serving diverse applications across governmental, private, and other sectors.

The hyperImmune globulin market research report is one of a series of new reports from The Business Research Company that provides hyperImmune globulin market statistics, including hyperImmune globulins industry global market size, regional shares, competitors with a hyperImmune globulin market share, detailed hyperImmune globulin market segments, market trends, and opportunities, and any further data you may need to thrive in the hyperImmune globulins industry. This hyperImmune globulin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hyperimmune globulins market size has grown strongly in recent years. It will grow from $1.91 billion in 2024 to $2.06 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increased government support, rise in healthcare expenditures.

The hyperimmune globulins market size is expected to see strong growth in the next few years. It will grow to $2.76 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to the increasing prevalence of infectious diseases, growing awareness about the benefits of hyperimmune globulin injections, increasing demand for immunoglobulins, rising prevalence of alpha-1 antitrypsin deficiency, rising incidence of immune deficiencies. Major trends in the forecast period include technological advancements and innovation, investment in research and development, demand for passive immunity treatments, advancements in plasma-derived therapies, and technological advancements in manufacturing.

The hyperimmune globulin market is set to grow due to the increasing prevalence of infectious diseases. These diseases, caused by pathogens such as viruses, bacteria, fungi, and parasites, are on the rise due to factors such as antimicrobial resistance, climate change, and population growth. Hyperimmune globulins play a crucial role in combating infectious diseases by providing immediate passive immunity through concentrated antibodies targeting specific pathogens. This aids in disease prevention or treatment, as seen in cases such as chronic hepatitis B, where the number of cases in the US increased by 17% from 2021 to 2022. Therefore, the growth of infectious diseases is directly impacting the hyperimmune globulin market.

Government efforts to advance healthcare research and development are poised to boost the hyperimmune globulins market in the coming years. These initiatives are escalating due to growing demand for innovative medical solutions and the necessity to confront emerging health issues. They play a crucial role in fostering the development and accessibility of hyperimmune globulins, particularly in combating specific infectious diseases effectively. For example, in 2022, the UK government allocated £260 million (US $270.65 million) through the Business, Energy, and Industrial Strategy (BEIS) and the Department of Health and Social Care (DHSC) to enhance healthcare research and manufacturing. This funding supports NHS-led health research, new privacy-preserving platforms for diagnostics and treatment, clinical research services, and also includes £60 million (US $63.60 million) to bolster life sciences manufacturing in the UK. Therefore, the increasing government focus on healthcare research and development is a key driver of the hyperimmune globulins market.

In April 2022, Grifols S.A., a pharmaceutical company based in Spain, acquired Biotest for an undisclosed sum. This acquisition positions Grifols to enhance and diversify its product portfolio, increase the availability of plasma therapies, operate the largest private European network of plasma centers with 87 centers, and stimulate revenue growth and margin expansion. Biotest, a biotechnology company based in Germany, specializes in hyperimmune globulins, which aligns with Grifols' strategic goals.

Major companies operating in the hyperimmune globulins market are F. Hoffmann-La Roche AG, Bayer AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Ltd., Fresenius Kabi AG, Grifols SA, Octapharma AG, Shanghai RAAS Blood Products Co. Ltd., Emergent BioSolutions Inc., Kedrion Biopharma Inc., LFB SA, Hualan Biological Engineering Inc., FFF Enterprises Inc., Taibang Biologic Group, Bio Products Laboratory (BPL) Ltd., ADMA Biologics, Cangene Corporation, Kamada Ltd., Saol Therapeutics Inc., Omrix Biopharmaceuticals Ltd., Shire, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., BioCare Inc.

North America was the largest region in the hyperimmune globulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperimmune globulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hyperimmune globulins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hyperimmune globulins market consists of sales of bayrab, hepaGam B, Tetanus Immune Globulin (TIG), variZIG, respiGam, and cytogam. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hyperimmune Globulins Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hyperimmune globulins market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hyperimmune globulins ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hyperimmune globulins market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Hepatitis B Hyperimmune Globulin; Rabies Hyperimmune Globulin; Tetanus Hyperimmune Globulin; Cytomegalovirus (CMV) Hyperimmune Globulin; Varicella-Zoster Virus (VZV) Hyperimmune Globulin; Respiratory Syncytial Virus (RSV) Hyperimmune Globulin; Other Types
• 2) By Route Of Administration: Intramuscular; Intravenous
• 3) By Application: Government Institution; Private Sector; Other Applications
• Subsegments:
• 1) By Hepatitis B Hyperimmune Globulin: Intramuscular Hepatitis B Hyperimmune Globulin; Intravenous Hepatitis B Hyperimmune Globulin
• 2) By Rabies Hyperimmune Globulin: Rabies Immune Globulin (Human); Rabies Immune Globulin (Equine)
• 3) By Tetanus Hyperimmune Globulin: Tetanus Immune Globulin (Human); Tetanus Immune Globulin (Equine)
• 4) By Cytomegalovirus (Cmv) Hyperimmune Globulin: Cmv Immune Globulin For Organ Transplantation; Cmv Immune Globulin For Neonatal Infection
• 5) By Varicella-Zoster Virus (Vzv) Hyperimmune Globulin: Vzv Immune Globulin For Post-Exposure Prophylaxis; Vzv Immune Globulin For Immunocompromised Patients
• 6) By Respiratory Syncytial Virus (Rsv) Hyperimmune Globulin: Rsv Immune Globulin For Infants And Children; Rsv Immune Globulin For Adults With Respiratory Conditions
• 7) By Other Types: Diphtheria Hyperimmune Globulin; Botulism Hyperimmune Globulin; Other Specialized Hyperimmune Globulins
• Companies Mentioned: F. Hoffmann-La Roche AG; Bayer AG; Takeda Pharmaceutical Company Limited; Baxter International Inc.; CSL Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hyperimmune Globulins Market Characteristics

3. Hyperimmune Globulins Market Trends And Strategies

4. Hyperimmune Globulins Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Hyperimmune Globulins Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hyperimmune Globulins PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hyperimmune Globulins Market Growth Rate Analysis
• 5.4. Global Hyperimmune Globulins Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hyperimmune Globulins Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hyperimmune Globulins Total Addressable Market (TAM)

6. Hyperimmune Globulins Market Segmentation

• 6.1. Global Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hepatitis B Hyperimmune Globulin
• Rabies Hyperimmune Globulin
• Tetanus Hyperimmune Globulin
• Cytomegalovirus (CMV) Hyperimmune Globulin
• Varicella-Zoster Virus (VZV) Hyperimmune Globulin
• Respiratory Syncytial Virus (RSV) Hyperimmune Globulin
• Other Types
• 6.2. Global Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intramuscular
• Intravenous
• 6.3. Global Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Government Institution
• Private Sector
• Other Applications
• 6.4. Global Hyperimmune Globulins Market, Sub-Segmentation Of Hepatitis B Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intramuscular Hepatitis B Hyperimmune Globulin
• Intravenous Hepatitis B Hyperimmune Globulin
• 6.5. Global Hyperimmune Globulins Market, Sub-Segmentation Of Rabies Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rabies Immune Globulin (Human)
• Rabies Immune Globulin (Equine)
• 6.6. Global Hyperimmune Globulins Market, Sub-Segmentation Of Tetanus Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tetanus Immune Globulin (Human)
• Tetanus Immune Globulin (Equine)
• 6.7. Global Hyperimmune Globulins Market, Sub-Segmentation Of Cytomegalovirus (Cmv) Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cmv Immune Globulin For Organ Transplantation
• Cmv Immune Globulin For Neonatal Infection
• 6.8. Global Hyperimmune Globulins Market, Sub-Segmentation Of Varicella-Zoster Virus (Vzv) Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vzv Immune Globulin For Post-Exposure Prophylaxis
• Vzv Immune Globulin For Immunocompromised Patients
• 6.9. Global Hyperimmune Globulins Market, Sub-Segmentation Of Respiratory Syncytial Virus (Rsv) Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rsv Immune Globulin For Infants And Children
• Rsv Immune Globulin For Adults With Respiratory Conditions
• 6.10. Global Hyperimmune Globulins Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diphtheria Hyperimmune Globulin
• Botulism Hyperimmune Globulin
• Other Specialized Hyperimmune Globulins

7. Hyperimmune Globulins Market Regional And Country Analysis

• 7.1. Global Hyperimmune Globulins Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hyperimmune Globulins Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hyperimmune Globulins Market

• 8.1. Asia-Pacific Hyperimmune Globulins Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hyperimmune Globulins Market

• 9.1. China Hyperimmune Globulins Market Overview
• 9.2. China Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hyperimmune Globulins Market

• 10.1. India Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hyperimmune Globulins Market

• 11.1. Japan Hyperimmune Globulins Market Overview
• 11.2. Japan Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hyperimmune Globulins Market

• 12.1. Australia Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hyperimmune Globulins Market

• 13.1. Indonesia Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hyperimmune Globulins Market

• 14.1. South Korea Hyperimmune Globulins Market Overview
• 14.2. South Korea Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hyperimmune Globulins Market

• 15.1. Western Europe Hyperimmune Globulins Market Overview
• 15.2. Western Europe Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hyperimmune Globulins Market

• 16.1. UK Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hyperimmune Globulins Market

• 17.1. Germany Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hyperimmune Globulins Market

• 18.1. France Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hyperimmune Globulins Market

• 19.1. Italy Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hyperimmune Globulins Market

• 20.1. Spain Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hyperimmune Globulins Market

• 21.1. Eastern Europe Hyperimmune Globulins Market Overview
• 21.2. Eastern Europe Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hyperimmune Globulins Market

• 22.1. Russia Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hyperimmune Globulins Market

• 23.1. North America Hyperimmune Globulins Market Overview
• 23.2. North America Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hyperimmune Globulins Market

• 24.1. USA Hyperimmune Globulins Market Overview
• 24.2. USA Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hyperimmune Globulins Market

• 25.1. Canada Hyperimmune Globulins Market Overview
• 25.2. Canada Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hyperimmune Globulins Market

• 26.1. South America Hyperimmune Globulins Market Overview
• 26.2. South America Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hyperimmune Globulins Market

• 27.1. Brazil Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hyperimmune Globulins Market

• 28.1. Middle East Hyperimmune Globulins Market Overview
• 28.2. Middle East Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hyperimmune Globulins Market

• 29.1. Africa Hyperimmune Globulins Market Overview
• 29.2. Africa Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hyperimmune Globulins Market Competitive Landscape And Company Profiles

• 30.1. Hyperimmune Globulins Market Competitive Landscape
• 30.2. Hyperimmune Globulins Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. CSL Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Hyperimmune Globulins Market Other Major And Innovative Companies

• 31.1. Fresenius Kabi AG
• 31.2. Grifols SA
• 31.3. Octapharma AG
• 31.4. Shanghai RAAS Blood Products Co. Ltd.
• 31.5. Emergent BioSolutions Inc.
• 31.6. Kedrion Biopharma Inc.
• 31.7. LFB SA
• 31.8. Hualan Biological Engineering Inc.
• 31.9. FFF Enterprises Inc.
• 31.10. Taibang Biologic Group
• 31.11. Bio Products Laboratory (BPL) Ltd.
• 31.12. ADMA Biologics
• 31.13. Cangene Corporation
• 31.14. Kamada Ltd.
• 31.15. Saol Therapeutics Inc.

32. Global Hyperimmune Globulins Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hyperimmune Globulins Market

34. Recent Developments In The Hyperimmune Globulins Market

35. Hyperimmune Globulins Market High Potential Countries, Segments and Strategies

• 35.1 Hyperimmune Globulins Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hyperimmune Globulins Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hyperimmune Globulins Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer